首页 | 官方网站   微博 | 高级检索  
     

肺腺癌对一代EGFR-TKIs原发耐药的危险因素分析
引用本文:孔君,杨雪,解卫平,孔辉. 肺腺癌对一代EGFR-TKIs原发耐药的危险因素分析[J]. 现代肿瘤医学, 2021, 0(6): 950-955
作者姓名:孔君  杨雪  解卫平  孔辉
作者单位:南京市第二医院结核科;南京医科大学第一附属医院(江苏省人民医院)呼吸与危重症医学科
基金项目:国家科技重大专项(编号:2018ZX10722301-002);国家自然科学基金(编号:81870054,81273571);江苏省卫生厅重点项目(编号:H201601)。
摘    要:目的:分析对一代表皮生长因子受体酪氨酸激酶抑制剂(epidermal growth factor receptor-tyrosine ki-nase inhibitors,EGFR-TKIs)原发耐药的EGFR突变肺腺癌患者的临床特征,为预测肺腺癌患者是否对一代EGFR-TKIs原发耐药提供依据.方法:收集2014年0...

关 键 词:EGFR  一代EGFR-TKIs  肺腺癌  原发性耐药  危险因素

Analysis of risk factors for first generation EGFR-TKIs resistance of lung adenocarcinoma
KONG Jun,YANG Xue,XIE Weiping,KONG Hui. Analysis of risk factors for first generation EGFR-TKIs resistance of lung adenocarcinoma[J]. Journal of Modern Oncology, 2021, 0(6): 950-955
Authors:KONG Jun  YANG Xue  XIE Weiping  KONG Hui
Affiliation:(Department of Tuberculosis,the Second Hospital of Nanjing,Jiangsu Nanjing 211100,China;Department of Pulmonary and Critical Care Medicine,the First Affiliated Hospital of Nanjing Medical University,Jiangsu Nanjing 210029,China)
Abstract:Objective:To analyze the clinical characteristics of the first generation of EGFR-TKIs resistant lung adenocarcinoma patients with EGFR mutation,provide basis for the selection of therapeutic agents for EGFR mutation patients.Methods:The clinical data of patients with lung adenocarcinoma admitted to the First Affiliated Hospital of Nanjing Medical University from January 2014 to April 2019 were retrospectively analyzed,following inclusion criteria:Patients applied first generation EGFR-TKIs as first-line treatment and followed up for more than 6 months.Based on the curative effect,patients were classified into the primary drug resistant(NR=40)and sensitive group(NS=237),then the clinical data of two groups of patients and progression-free survival after the treatment of TKIs were compared.Results:The incidence of primary resistance was 14.4%.There were statistically significant differences in smoking index(P=0.004)and lymph node metastasis(P=0.03).Patients with NSE≥10.725 ng/mL and tumor diameter≥3.55 cm were more likely to be resistant to first-generation EGFR-TKIs(P<0.05),and the AUC values of each factor were 0.615 and 0.716,respectively.Combined with NSE and tumor diameter,the AUC was 0.735(95%CI:0.665~0.804).Combined with NSE,tumor diameter and smoking index,the AUC was 0.751(95%CI:0.679~0.822),which was better than the single index.Multi-factor logistic regression analysis confirmed that smoking index,lesion diameter and serum NSE concentration were independent influencing factors for predicting primary EGFR-TKIs resistance in patients with EGFR-sensitive mutations(P<0.05).Conclusion:Those with smoking index≥400,lesion diameter≥3.55 cm and serum NSE concentration≥10.725 ng/mL are more likely to be resistant to the first-generation EGFR-TKIs.The prediction accuracy of primary resistance to first generation EGFR-TKIs is low,however the prediction model based on the three factors could improve the accuracy.
Keywords:EGFR  first generation EGFR-TKIs  lung adenocarcinoma  primary resistance  risk factors
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号